Kaminski Rafal M, Livingood Matthew R, Rogawski Michael A
Epilepsy Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-4457, U.S.A.
Epilepsia. 2004 Jul;45(7):864-7. doi: 10.1111/j.0013-9580.2004.04504.x.
Low-frequency (6 Hz), long-duration (3 s) electrical stimulation in mice produces seizures characterized by immobility, focal clonus, and automatic behaviors reminiscent of human limbic epilepsy. Renewed interest has been expressed in this seizure model with the recognition that it is sensitive to a broad spectrum of anticonvulsants (AEDs) and may have distinct pharmacologic responsiveness from other in vivo tests of AED efficacy. Here we sought to determine whether the progesterone-derived neuroactive steroid allopregnanolone (5alpha,3alpha-P) and several structural analogues with varying degrees of activity as positive allosteric modulators of gamma-aminobutyric acid (GABA)A receptors are protective in the 6-Hz seizure model.
Mice were pretreated with neuroactive steroids (15 min before) or clonazepam (CZP; 30 min before) to 6-Hz corneal stimulation (32 mA). Animals that failed to exhibit immobility were considered protected.
The neuroactive steroids prevented 6-Hz seizures with rank order of potencies (ED50 values): ganaxolone (6.3 mg/kg) > 5alpha,3alpha-P (14.2 mg/kg) > or = 5beta,3alpha-P (14.4 mg/kg) > 5alpha,3beta-P (>100 mg/kg). CZP also was protective (ED(50) value, 0.075 mg/kg). The potencies of the neuroactive steroids and CZP are similar to their previously reported activities in the pentylenetetrazol (PTZ) seizure model.
Neuroactive steroids have comparable potencies in the 6-Hz and PTZ models. Their structural specificity in both models corresponds with their activities as positive allosteric modulators of GABAA receptors, although ganaxolone is more potent than expected, probably because it has greater bioavailability. The 6-Hz model may be a valuable tool in drug development for the identification of GABAergic AEDs.
对小鼠进行低频(6赫兹)、长时间(3秒)的电刺激会引发癫痫发作,其特征为不动、局灶性阵挛以及类似人类边缘叶癫痫的自动行为。随着人们认识到该癫痫模型对多种抗惊厥药物(AEDs)敏感,且在AED疗效的其他体内试验中可能具有不同的药理反应性,对其兴趣再度燃起。在此,我们试图确定孕酮衍生的神经活性甾体别孕烷醇酮(5α,3α-P)以及几种作为γ-氨基丁酸(GABA)A受体正性变构调节剂具有不同活性程度的结构类似物在6赫兹癫痫模型中是否具有保护作用。
给小鼠预先使用神经活性甾体(提前15分钟)或氯硝西泮(CZP;提前30分钟),然后进行6赫兹角膜刺激(32毫安)。未出现不动状态的动物被视为受到保护。
神经活性甾体预防6赫兹癫痫发作的效价顺序(半数有效剂量[ED50]值)为:加奈索酮(6.3毫克/千克)>5α,3α-P(14.2毫克/千克)≥5β,3α-P(14.4毫克/千克)>5α,3β-P(>100毫克/千克)。CZP也具有保护作用(ED50值为0.075毫克/千克)。神经活性甾体和CZP的效价与其先前在戊四氮(PTZ)癫痫模型中报道的活性相似。
神经活性甾体在6赫兹和PTZ模型中具有相当的效价。它们在两种模型中的结构特异性与其作为GABAA受体正性变构调节剂的活性相对应,尽管加奈索酮比预期更有效,可能是因为它具有更高的生物利用度。6赫兹模型可能是药物开发中用于鉴定GABA能AEDs的有价值工具。